Skip to main content

The influence of oxygen and oxidative stress on de novo acquisition of antibiotic resistance in E. coli and Lactobacillus lactis

Abstract

Background

Bacteria can acquire resistance through DNA mutations in response to exposure to sub-lethal concentrations of antibiotics. According to the radical-based theory, reactive oxygen species (ROS), a byproduct of the respiratory pathway, and oxidative stress caused by reactive metabolic byproducts, play a role in cell death as secondary killing mechanism. In this study we address the question whether ROS also affects development of resistance, in the conditions that the cells is not killed by the antibiotic.

Results

To investigate whether oxygen and ROS affect de novo acquisition of antibiotic resistance, evolution of resistance due to exposure to non-lethal levels of antimicrobials was compared in E. coli wildtype and ΔoxyR strains under aerobic and anaerobic conditions. Since Lactococcus lactis (L. lactis) does not have an active electron transport chain (ETC) even in the presence of oxygen, and thus forms much less ROS, resistance development in L. lactis was used to distinguish between oxygen and ROS. The resistance acquisition in E. coli wildtype under aerobic and anaerobic conditions did not differ much. However, the aerobically grown ΔoxyR strain gained resistance faster than the wildtype or anaerobic ΔoxyR. Inducing an ETC by adding heme increased the rate at which L. lactis acquired resistance. Whole genome sequencing identified specific mutations involved in the acquisition of resistance. These mutations were specific for each antibiotic. The lexA mutation in ΔoxyR strain under aerobic conditions indicated that the SOS response was involved in resistance acquisition.

Conclusions

The concept of hormesis can explain the beneficial effects of low levels of ROS and reactive metabolic byproducts, while high levels are lethal. DNA repair and mutagenesis may therefore expedite development of resistance. Taken together, the results suggest that oxygen as such barely affects resistance development. Nevertheless, non-lethal levels of ROS stimulate de novo acquisition of antibiotic resistance.

Peer Review reports

Background

Bacteria can acquire antibiotic resistance by adapting cellular physiology, DNA mutations, and horizontal transfer of resistance genes [1]. DNA mutations can occur as a result of exposure to non-lethal concentrations of antimicrobials [2]. These mutations can modify the cellular targets of antibiotics, activate antibiotic efflux pumps, generate enzymes that disable antibiotics, and reduce the permeability of membranes to antibiotics to make bacteria resistant [3, 4]. While the role of mutations in development of de novo resistance has been documented to some extent [5,6,7], the driving factors for mutations in the bacterial DNA are less well described.

According to the radical-based theory, exposure to bactericidal antibiotics results in the formation of reactive oxygen species (ROS) and reactive metabolic byproducts as a secondary effect that hastens bacterial cell death [8,9,10]. The overproduction of ROS damages the DNA, proteins, lipids, and nucleotides pool, and in particular causes the oxidation of guanine to 8-oxo-guanine [11]. Besides being lethal, ROS can also enhance mutation rates [12]. In fact, the overall effect of ROS and reactive metabolic byproducts may be hormetic [13], as low concentrations enable rapid adaptation, while high level are lethal [14]. Sub-inhibitory doses of ciprofloxacin generate a resistant mutant subpopulation through ROS formation and sigma-S general stress response activity [15]. Furthermore, multidrug resistance induced by sublethal levels of antibiotics correlates with ROS-induced mutagenesis [16]. ROS has been described as a key factor in antibiotic-induced SOS mutagenesis, and treatment with the antioxidant N-acetylcysteine reduces ROS and blocks SOS-mediated mutagenesis [17]. Based on the above considerations we hypothesized that the oxidative stress caused by ROS plays a central role in de novo acquisition of antibiotic resistance.

Escherichia coli is a facultative anaerobic prokaryote, commonly found in the human gastrointestinal tract [18]. The gene oxyR in E. coli codes for an oxidative stress regulator, mitigating levels of hydrogen peroxide under aerobic conditions [19], and oxyR is involved in preventing SOS-induced DNA damage by hydrogen peroxide [20] Additionally, oxyR regulon mutants of E. coli and Salmonella typhimurium were associated with antibiotic resistance [21]. Because E. coli is well described and thoroughly studied in many aspects, it is the primary model organism used in this study. The lactic acid bacterium Lactococcus lactis is a fermentative bacterium, that can also grow in the presence of oxygen, but even then does not possess a complete electron transport chain (ETC) [22]. However, when both heme and oxygen are present, L. lactis can establish an ETC, resulting in NADH oxidation and aerobic respiration [23] and hence the formation of ROS. It is therefore used throughout this study to separate the respective roles of oxygen and ROS generated by the ETC in development of de novo antimicrobial resistance.

The information available in the scientific literature as summarized above lead us to formulate the following hypothesis: ROS possibly is a driving factor for de novo acquisition of resistance in bacteria surviving exposure to bactericidal antibiotics. The effect of ROS is likely to be hormetic, in the sense that low levels of stress caused by bactericidal antimicrobials is beneficial for the cell as resistance is acquired. High levels, however, are lethal. This hypothesis was examined by documenting development of resistance under aerobic and anaerobic conditions, in wildtype E. coli and the ΔoxyR mutant E. coli that has reduced ability to remove ROS [24]. L. lactis was used as a biological control to separate between the effects of oxygen itself and ROS.

Results

Acquisition of resistance under aerobic and anaerobic conditions

In order to evaluate the effect of oxygen on the development of resistance by E. coli exposed to sub-lethal levels of antibiotics, initially fully susceptible cells were grown in the presence of stepwise increasing concentrations of four antimicrobials. The evolution of resistance defined as the ability to grow at certain concentrations of the antibiotics to the bactericidal antibiotics amoxicillin, enrofloxacin, kanamycin, and the bacteriostatic antibiotic tetracycline under aerobic and anaerobic conditions was compared (Fig. 1). To provide additional insight into the role of cellular systems that induce stress caused by reactive oxygen species (ROS), two E. coli strains were used in these experiments: The wild-type MG1655 and the ΔoxyR single gene deletion strain derived from it. OxyR is a transcriptional dual regulator of antioxidant gene expression in response to oxidative stress. Hence, the cell will produce more ROS when oxyR is knocked out [24]. In approximately 30 days, resistance against bactericidal antibiotics (amoxicillin, enrofloxacin, and kanamycin) reached a high concentration (512–2048 µg/mL), while resistance against the bacteriostatic tetracycline was limited to around 32 µg/mL (Fig. 1).

Fig. 1
figure 1

Acquisition of resistance to amoxicillin (A, E, I), enrofloxacin (B, F, J), kanamycin (C, G, K), and tetracycline (D, H, L) of E. coli wild-type MG1655 (blue: anaerobic/black: aerobic) and the ΔoxyR knockout (green: anaerobic/red: aerobic) strains. The Y-axis indicates the antibiotic concentration at which the cells were able to grow. The top 4 panels (A-D) show wild-type MG1655, the second set of panels (E-H) show the ΔoxyR mutant, and the third set of panels (I-L) compares the resistance concentrations of each strain reached at day 20

There were only minor differences in the final concentrations reached by the wild-type MG1655 under aerobic or anaerobic incubations. The only clear difference was that the final concentration for amoxicillin and kanamycin was double after aerobic growth compared to anaerobic (Fig. 1A and C). In the case of the ΔoxyR mutant, the aerobic incubations reached higher resistance levels and reached them faster, especially in the case of bactericidal antibiotics (Fig. 1E-G). After 20 days, the resistance concentrations reached showed major differences. The ΔoxyR mutant strain under aerobic conditions reached to the highest concentrations compared to the other strains (Fig. 1I-L).

Acquisition of resistance in E. coli and L. lactis in rich medium

To separate the influence of oxygen itself from that of oxygen derived compounds, such as ROS, the experiments were repeated on L. lactis. As one of very rare microbes L. lactis is homofermentative, both under aerobic and anaerobic conditions, because it lacks the pathway for heme biosynthesis and hence cannot form an endogenous ETC. However, an active respiratory chain is established when the culture is grown in the presence of heme. These features make L. lactis an ideal model organism to address the question of the influence of different levels of activity of the ETC on the development of antibiotic resistance. As L. lactis can only be cultured in rich medium, the experiments were repeated for E. coli grown in rich LB medium as well to facilitate the comparison.

After 30 days the resistance to amoxicillin was still in the low range of concentrations (1 or 2 µg/mL) in L. lactis, compared to 1024 µg/mL in E. coli (Fig. 2A). Because L. lactis is intrinsically resistant to enrofloxacin and kanamycin, these were omitted (Fig. 2B and C). Instead, moxifloxacin and chloramphenicol were used. During the tetracycline resistance development, tolerated antibiotic concentrations increased from 0.25 µg/mL to 4 µg/mL (16-fold) in L. lactis, from 0.5 µg/mL to 16 µg/mL (32-fold) in E. coli (Fig. 2D). L. lactis barely acquired amoxicillin resistance even with added heme (Fig. 2E). Only in the case of moxifloxacin resistance did the addition of heme make a noticeable difference (Fig. 2F), but not on the evolution of resistance to the bacteriostatic antibiotics: chloramphenicol and tetracycline (Fig. 2G and H).

Fig. 2
figure 2

Acquisition of resistance by E. coli MG1655 to amoxicillin (A), enrofloxacin (B), kanamycin (C), tetracycline(D) in rich medium (LB), and L. lactis MG1363 to amoxicillin (A), tetracycline (D) in rich medium (M17). Acquisition of resistance to amoxicillin (E), moxifloxacin (F), chloramphenicol (G), and tetracycline (H) by L. lactis and Heme-added L. lactis in M17 medium

ROS production levels in antibiotic resistant strains

The formation of ROS was measured by fluorescent microscopy. Strains of E. coli were made resistant to the amoxicillin, enrofloxacin, kanamycin and tetracycline. On exposure to these antibiotics, cells exposed to the bactericidal antibiotics had higher ROS production than strains grown in the presence of the bacteriostatic tetracycline (Fig. 3A). Compared to the MG1655 wild type, the generation of ROS in ΔoxyR strains was significantly enhanced in the presence of enrofloxacin and kanamycin. In L. lactis, only heme added strains that were exposed to the bactericidals amoxicillin and moxifloxacin had noticeable ROS production (Fig. 3B). In the presence of the bacteriostatic antibiotic chloramphenicol and tetracycline, almost no ROS was generated in L. lactis whether heme was added or not. These observations indicate that exposure to bactericidal antibiotics increases ROS production in the oxyR knockout to higher levels than in wildtype E. coli, and similarly in heme added L. lactis compared to L. lactis growing in regular medium without heme.

Fig. 3
figure 3

ROS measurement in antibiotic resistant E. coli and L. lactis under fluorescent microscopy. Resistant strains were treated with the highest concentrations of antibiotics that still allowed growth. The fluorescent dye H2DCFDA was used to detect the ROS. Cells with ROS production were counted with ImageJ, E. coli (A), L. lactis (B). Means ± SD, statistical significance was investigated using a one-way ANOVA *p < 0.05, **p < 0.001, ***p < 0.0001

Whole genome sequencing to document mutations during resistance evolution

To identify mutations that accompany the acquisition of resistance, the genomic DNA of the strains resistant to the highest antibiotic concentrations was sequenced entirely. The strains to be sequenced were the final incubations of the evolution experiments. In case the two replicates did not have an identical MIC, the most resistant strain was selected. Variant calling analysis was used to document nucleotide changes as summarized in Fig. 4. The most frequently observed types of nucleotides changes were AT to CG and CG to GC (Fig. 4). Higher numbers of these two types were detected under anaerobic conditions than under aerobic conditions. The MG1655 strain in aerobic conditions had the fewest mutations. L. lactis mainly acquired deletion mutations less of 20 bp (Fig. 4). After excluding the same mutations observed in strains grown without antibiotics, the unique mutated genes in each strain were identified and summarized in Venn diagram (Figs. 5 and 6A-D). DNA copy number variations are shown in Fig. 7; Table 1, and Fig. 6E-L.

Fig. 4
figure 4

Heat map of the types of nucleotide changes in MG1655 and ΔoxyR under aerobic and anaerobic conditions. The color codes for the number of specified mutations observed. (A); L. lactis, heme-added L. lactis and E. coli in rich medium (B). N: no treatment control, A: amoxicillin, E: enrofloxacin, K: kanamycin, T: tetracycline, M: moxifloxacin, C: chloramphenicol. Ins: insertion, del: deletion, dup: duplication

Fig. 5
figure 5

Overlap of mutated genes in the anaerobic wild-type MG1655 (blue oval), the aerobically grown wild-type MG1655 (yellow oval), the anaerobic mutant ΔoxyR (green oval), and the aerobic mutant ΔoxyR (red oval) made resistant to amoxicillin (A), enrofloxacin (B), kanamycin (C), and tetracycline(D)

Fig. 6
figure 6

Mutated genes in wild-type L. lactis and heme-added L. lactis after evolution of resistance to amoxicillin (A), moxifloxacin (B), chloramphenicol (C), and tetracycline (D). DNA copy number of WGS of L. lactis resistant to amoxicillin (E, F), moxifloxacin (G, H), chloramphenicol (I, J), and tetracycline (K, L) in no heme-added L. lactis (E, G, I, K) is compared to heme-added L. lactis (F, H, J, L)

Fig. 7
figure 7

Variation of DNA copy numbers in whole genome sequencing (WGS) over the entire genome of the anaerobically grown wild-type MG1655 (A, E, I, M), aerobic wild-type MG1655 (B, F, J, N), anaerobic mutant ΔoxyR (C, G, K, O), and aerobic mutant ΔoxyR (D, H, L, P) made resistant to amoxicillin (A-D), enrofloxacin (E-H), kanamycin (I-L), and tetracycline(M-P)

Table 1 Amoxicillin resistant strains’ amplification contigs. Fragments of the chromosomal DNA that all include the ampC gene but vary in length, are multiplied by the indicated factor

In all amoxicillin resistant strains, the genes ampC, frdD, and cpxA were mutated (Fig. 5A). AmpC is the serine beta-lactamase with substrate specificity for amoxicillin, FrdD is the fumarate reductase subunit D [25]. CpxA is a membrane-localized sensor kinase that activates CpxR, which promotes efflux complex expression [26]. The four resistant strains all contained a differential amplification contig that included ampC and frdD (Fig. 7A-D; Table 1). In the resistant strains, some outer membrane porin genes such as ompF and ompC were mutated. These are associated with reduced permeability to antibiotics. Only the ΔoxyR strain under aerobic conditions had a mutation in acrB, which codes for an efflux pump.

Strains made resistant to enrofloxacin shared two common mutated genes, DNA gyrase gene, gyrA, and DNA topoisomerase gene, parC, which are well-known quinolone resistance genes [27] (Fig. 5B). Other typical quinolone resistance related genes, gyrB and parE were mutated in the ΔoxyR strain under aerobic conditions, parE was mutated as well in the ΔoxyR strain under anaerobic conditions and the MG1655 strain under aerobic conditions. Several DNA or RNA helicase genes were mutated, such as dinG, hrpA, and yoaA. Efflux pump associated genes like acrA, phoQ were mutated in the MG1655 strain under aerobic conditions, and acrR, soxR in the ΔoxyR strains both under aerobic and anaerobic conditions. The MG1655 strain under anaerobic conditions contained a cryptic prophage e14 deletion (Fig. 7E), which is a well-known mutation associated with quinolone resistance [28]. In lexA, which inhibits a number of genes involved in the SOS response to DNA damage [29, 30], a Gly85Ser mutation was observed in the ΔoxyR strain under aerobic conditions.

The common mutated gene in kanamycin resistant strains is fusA (Fig. 5C). During the translation elongation, FusA catalyzes the GTP-dependent ribosomal translocation step [31]. This mutation may cause antibiotic target alteration. The MG1655 strain under anaerobic conditions had a 5 kb deletion from gene yaiT to yaiW. (Fig. 7I). This deletion includes sbmA, a peptide antibiotic transporter. The sbmA mutation also occurred in both the MG1655 and ΔoxyR strains under aerobic conditions.

There was no common mutated gene in the tetracycline resistant strains (Fig. 5D). However, a few resistance-related mutated genes were identified. For instance, genes that code for the antibiotic efflux pumps, such as acrA, acrB, acrR, mlaF were mutated. Genes that associated with antibiotic target alteration or protection, like rpoB and rpsJ; and genes associated with reduced permeability to antibiotics, such as ompF were also mutated. The MG1655 strains under aerobic and anaerobic conditions both contained a 2-fold amplification region from insH1 to insH3 of around 400 kb length (Fig. 7M and N). The amplified region in the ΔoxyR strain under aerobic conditions started from insH1 as well but stopped in insF1 resulting in a total length of about 800 kb (Fig. 7P). A roughly 100 kb amplification region was observed in the ΔoxyR strain under anaerobic conditions from gene insH1 to yahH (Fig. 7O).

Mutations in L. lactis with and without added heme

In L. lactis, the number of mutated genes in strains made resistant to bactericidal antibiotics was higher than in strains resistant to bacteriostatic antibiotics (Fig. 6). When heme was added to generate a functional ETC L. lactis strains that evolved resistance contained mutations in two genes, purM (Gly250Val), and aroH (Arg168Gly). PurM is involved in purine metabolism [32]. AroH is involved in the early step of aromatic amino acid biosynthesis [33]. In amoxicillin resistant L. lactis, the mutated genes, pbp2B and pbpX were observed both with and without added heme. Mutations in these two genes may cause antibiotic action targets modification. The target genes ponA and cdsA were mutated in the heme-added strain as well (Fig. 6A).

The common mutated genes in moxifloxacin resistant strains were gyrA, parC, and llmg1807. The genes rpoC were mutated in the no heme-added condition, and rpoB in heme-added condition (Fig. 6B). There was a roughly 45 kb length deletion from llmg1359 to llmg1411 in no heme-added strain (Fig. 6G). A 42 kb amplification, with around 4-fold copy number increase, from ps301 to ps357 occurred in the heme-added moxifloxacin resistant strain (Fig. 6H). Only one mutated gene, rplD (Lys68Asn) was detected in no heme-added chloramphenicol resistant L. lactis. RplD, the 50 S L4 ribosomal protein, was identified in Neisseria gonorrhoeae as a macrolide resistance protein [34]. The same gene rplD was mutated but with different amino acid change, Lys68Glu, in the heme-added chloramphenicol resistant L. lactis. The tetracycline resistant L. lactis strains had two common mutated genes, llmg0323 and rpsJ. Llmg0323 is a transcriptional regulator. RpsJ, 30 S ribosomal protein S10 is a tetracycline-resistant ribosomal protection protein [35].

Functional annotation of mutated genes associated with antibiotic resistance

In order to group the mutated genes, they were clustered functionally according to the phylogenetic classification (Fig. 8). The IMG/M database of Clusters of Orthologous Groups (COG) was used to annotate all the mutated genes and classify them [36]. There were no clear differences in which classes of genes were mutated between E. coli wild-type MG1655 and the ΔoxyR strains under aerobic and anaerobic conditions (Fig. 8A). However, the different antibiotics caused mutations in different classes of genes. The majority of genes mutated after exposure to amoxicillin, enrofloxacin, and kanamycin are involved in cellular processing and signaling, information storage and processing, and metabolism, respectively (Fig. 8A). In L. lactis, half the number of mutated genes in amoxicillin exposed strains is involved in cellular processes and signaling function. The genes mutated by growth in the presence of moxifloxacin were evenly distributed over information and signaling and metabolism (Fig. 8B). The number of mutated genes in tetracycline-incubated E. coli, and chloramphenicol, tetracycline-incubated L. lactis were clearly lower than those of cells exposed to bactericidal antibiotics, making the COG comparison problematic.

Fig. 8
figure 8

Cluster of orthologous groups (COG) classifications of mutated genes. A: amoxicillin, E: enrofloxacin, K: kanamycin, T: tetracycline, M: moxifloxacin, C: chloramphenicol; AN: anaerobic condition, AE: aerobic condition. Panel A: E. coli; Panel B: L. lactis. The IMG/M was used to classify the genes (https://img.jgi.doe.gov/)

Discussion

The role of oxygen in the killing of bacteria by bactericidal antibiotics has been the subject of debate since the “radical based” theory was proposed, which suggests that reactive oxygen species form a secondary killing mechanism in addition to the primary target [8, 37, 38]. This study examined the role of oxygen in de novo acquisition of resistance by comparing resistance development under aerobic and anaerobic conditions. In the human intestines, E. coli is exposed to anaerobic or micro-aerobic conditions [39]. Anaerobic growth may therefore be more natural than the aerobic conditions used in most experiments involving E. coli. To test the influence of oxidative stress, resistance adaptation was examined in an E. coli ΔoxyR mutant strain. L. lactis was used to separate between the effects of oxygen and those of ROS, because even under aerobic conditions, it does not possess a complete ETC, unless heme is supplied in the medium [40]. Hence, it only forms ROS when heme is present in the medium, but not in the absence, even when oxygen is available.

Hormesis

The de novo acquisition of resistance in wildtype E. coli with and without oxygen was relatively similar. The presence of oxygen in itself seems to have no major influence on resistance development. However, under anaerobic conditions, reactive metabolic byproducts (RMB), particularly reactive electrophilic species, accumulate in antibiotic-treated E. coli [10]. These RMB contribute to cell death in a similar manner as ROS in aerobic conditions. Possibly ROS and RMB have relatively similar effects on resistance development. Nonetheless, under aerobic conditions, ΔoxyR strain became resistant to bactericidal antimicrobials faster than the wildtype. The oxyR gene codes for a regulatory protein that regulates a system of proteins that protect the cell from ROS and comparable stressors [41]. The presence of oxygen accelerated the acquisition of resistance in the ΔoxyR strains, indicating that the extra ROS indeed stimulated this process. Hyperproduced ROS damage DNA and the nucleotide pool. The 8-oxo-guanine derived from guanine results in faulty DNA replication, accompanied by the general stress response [42, 43]. The cell’s repair systems tend to increase rates of mutagenesis [44].

During antibiotic resistance acquisition, the differences can be observed in the middle and late stages of resistance development, possibly because at that stage increasing numbers of cells accumulate general stress-induced mutations. The observation that heme-added L. lactis gained moxifloxacin resistance faster also points to an effect of ROS (Fig. 2F), generated by the ETC that was induced by the addition of heme. These observations can be understood in the framework of hormesis [45, 14]. While mild stress is beneficial in the form of the ability to more rapidly adapt to the presence of antimicrobials, high levels of the same stressors can cause cell death. When radical-based stress levels are low, a relatively moderate increase of the oxidative stress seems to accelerate the acquisition of resistance. This modest amount of oxidative stress often occurs in environmental microbes and correlates well with antibiotic-resistance gene abundance [46].

Mutations accompanying resistance development

Far higher mutation frequencies of AT to CG and CG to GC were observed in anaerobically grown E. coli than in aerobic conditions. A likely cause is the DNA damage induced by acidic fermentation [47, 48]. However, these kinds of single nucleotide change mutations and the < 20 bp deletion mutations which occurred in the L. lactis were almost never situated in resistance-related genes hot spots. Anaerobically grown untreated E. coli strains also had high mutation frequencies, indicating that this kind of mutation did not influence resistance development.

Various E. coli strains which evolved resistance to the bactericidal antibiotics had common mutated genes, for instance, ampC for amoxicillin, gyrA and parC for enrofloxacin, and fusA for kanamycin. These genes are known to play crucial roles in resistance acquisition [2]. In addition to the mutated genes that are common to all strains with induced resistance, there are mutations in genes that are specific for a certain strain and that follow logically from the characteristics of that strain. Only the amoxicillin resistant E. coli ΔoxyR strain under aerobic conditions had an acrB mutation that may increase amoxicillin efflux. In the aerobically grown ΔoxyR enrofloxacin resistant strain, a mutation was observed in lexA. lexA codes for a transcriptional repressor, auto-cleavage of LexA triggers the SOS response [49]. Mutagenic states caused by the SOS stress response may enhance the de novo acquisition of antibiotic resistance [50, 51]. The Gly85Ser mutation located on the lexA auto-cleavage site [52], may increase the rate of acquisition of resistance. During kanamycin exposure, SbmA mutations included Phe6fs in the aerobically grown wildtype strain, total deletion in the anaerobically grown wildtype, and Ser372* in the aerobically grown ΔoxyR strain. These mutations block SbmA activity, thus inhibiting kanamycin uptake [53]. Three of the four cell lines exposed to kanamycin acquired mutations in sbmA that reduced kanamycin uptake. Only the anaerobically grown ΔoxyR strain missed a sbmA mutation, and indeed developed less kanamycin resistance.

Mutations in the multidrug efflux pump subunit coding genes acrA, acrB, acrD, and their regulator acrR, emerged in four antibiotic-resistant E. coli strains. Additionally, mutations in the outer membrane porin genes envZ (ompB), ompC, and ompF appeared in the amoxicillin, kanamycin, and tetracycline resistant E. coli strains. This could lead to increased resistance when these strains are exposed to other antibiotic treatments due to the cross-resistance [54]. Comparison with a similar dataset in which E. coli wildtype evolved resistance resistant against the same four antimicrobials showed that apart from the commonly mutated genes described above, there were no other genes mutated in both datasets [3]. Hence, we must conclude that most mutations that occur during the acquisition of antibiotic resistance were random events that may or may not contribute to the development of resistance. Selection and co-selection afterwards during continued exposure to a specific antimicrobial determine the final list of mutations.

Functional distribution of mutations

The distribution over functional categories of genes that mutated as a result of exposure to antimicrobials was similar in the various types of cells exposed. This distribution can be related to the mechanisms of action of the particular antibiotic. Both in the dataset on mutations after resistance was built up against two antibiotics [3] and in the present dataset, a specific antibiotic correlates with specific functions. Mutations accompanying resistance to amoxicillin occur in genes coding for proteins involved in cellular processing and signaling and metabolism. This corresponds to the disruption of cell wall construction by beta-lactam antibiotics [55]. Enrofloxacin correlates primarily to genes concerning information storage and processing, due to the inhibition of DNA replication [56], and also to metabolism. Kanamycin mutations are mainly in the area of metabolism, while tetracycline mutations are about evenly divided over cellular processing and signaling and information storage and processing, which also can be understood in the framework of the inhibition of protein synthesis by tetracyclines [57, 58]. The distribution in L. lactis was similar to that in E. coli.

Prolonged exposure to the beta-lactam antibiotic amoxicillin resulted in the amplification of a chromosomal DNA fragment centered around the ampC gene [7]. The multiplication of a 2.5 kb fragment was observed in the aerobically grown MG1655 strain. The amplified segments were larger in the anaerobically grown MG1655 strain (53 kb) and in the mutant ΔoxyR both under aerobic (59 kb) and anaerobic (5.5 kb) conditions. This indicates that the same process was taking place, but not in exactly the same manner. The fragment containing the ampC gene resembled known plasmid-bound beta-lactam resistance genes and could be transferred to a susceptible E. coli strain, that became resistant after this transfer [59]. Plasmids carrying beta-lactam resistance genes are frequently detected in clinical or environmental microorganisms [60]. These observations suggest that the de novo development of resistance may play a bigger role in spreading of antimicrobial resistance than previously presumed. A similar duplication of part of the chromosome was also observed as a result of tetracycline exposure. In this case, the copy number was only 2-fold at most and it is doubtful that it played a major role in the acquisition of resistance, also because gene amplification is not known as a tetracycline resistance mechanism.

Conclusion

The effects of ROS and reactive metabolic byproducts on development of antimicrobial resistance in response to exposure to non-lethal concentrations of antibiotics can be understood by the principle of hormesis. High levels of radical-based stress are lethal, while low levels can increase the rate of acquisition of resistance and thus for the survival of the cell. The role of oxygen in de novo acquisition of antibiotic resistance turned out to be indirect as a necessary condition for the generation of ROS. Under anaerobic conditions, the reactive metabolic byproducts seem to function in a similar manner as ROS under aerobic conditions. Still, these stresses caused by reactive compounds remain at a low level when antibiotic concentrations are non-lethal, and the relatively low levels of stress under these conditions accelerate resistance acquisition. By definition, at lethal levels the cells die and no resistance can develop.

Materials and methods

Bacterial strains, media and growth conditions

The antibiotic-sensitive wildtype strains E. coli MG1655 and L. lactis MG1363 were used throughout the study. The oxyR gene knockout mutant strain JW3933-3 was obtained from the Keio collection [61], and the kanamycin-resistant cassette was removed using the pCP20 plasmid by FLP Recombination. E. coli strains were grown in LB medium or a phosphate-buffered (100 mM NaH2PO4) defined minimal medium containing 55 mM glucose [62]. L. lactis was grown in 10% Lactose M17 broth medium. E. coli was grown at 37 °C, L. lactis was grown at 30 °C, and both were shaken at 200 rpm. Anaerobic culture DURAN® bottles with a butyl rubber stopper and an open topped screw cap, were filled with medium, inoculated with a syringe. Resazurin was used as oxygen indicator, and these tubes were autoclaved separately. L. lactis under aerobic respiration conditions was grown with further addition of heme (Sigma) to a final concentration of 2 µg/mL. Amoxicillin, enrofloxacin, kanamycin, tetracycline, moxifloxacin, and chloramphenicol stock solutions (10 mg/mL) were filter sterilized through a 0.2 µM filter and stored at 4 °C. Fresh antibiotic solutions were made every 3 days.

Evolution experiments

In order to induce resistance to each antibiotic and test the susceptibility of the strains, the MICs measurement was performed by serial dilution followed by a determination of the initial antibiotic concentrations (Tables 2 and 3).

Table 2 Initial MICs of E. coli strains
Table 3 Initial MICs of L. lactis strains

Evolution experiments inducing resistance were performed as described previously [63]. Briefly, individual colonies of each wild-type strain were isolated and cultured overnight under the specified conditions. Subsequently, fresh culture tubes or anaerobic bottles were inoculated with bacterial volume calculated to result in an initial OD600 of 0.1. Antibiotics were added at one-quarter of the MICs. Antibiotic-free groups were cultured under the exact same conditions as control. Following overnight incubation, if the antibiotic-treated group’s OD600 exceeded 75% of the control’s OD600, a portion of the antibiotic-treated culture was transferred to two new culture systems. These were supplemented with antibiotics at both twice the initial concentration and the original concentration. After another overnight culture, if the higher antibiotic concentration group’s OD600 surpassed 75% of the lower concentration group’s OD600, the former’s bacterial solution was selected; otherwise, the latter’s solution was chosen. The antibiotic concentration doubling continued until further doubling wasn’t possible and bacterial growth stabilized. Each strain’s evolution experiment was independently performed at least twice. In all experiments, cultures without antibiotic exposure were used as controls. MICs was detected three times a week to monitor resistance.

MICs was measured in 96-well plates in a spectrophotometer plate reader (Thermo Fisher Scientific) at 37oC. Each well contains 150 µL final volumes with the OD600 of 0.05 bacteria, antibiotics concentrations ranged from 0.25 to 2048 with steps of a factor of two. After overnight culture, the lowest concentration that yielded a final OD600 < 0.2 was considered the MICs.

ROS measurement

To determine the formation of ROS, overnight cultured E. coli and L. lactis strains made resistant to a specific antibiotic were diluted to OD600 of 0.2 and exposed to the highest concentration of these antibiotics that still allowed growth. After administration of the antibiotic, cells were cultured for 3 h at 37 °C (E. coli) or 30 °C (L. lactis) shaking at 200 rpm. Cell cultures were incubated with 5 µL 10 mM H2DCFDA (Sigma) fluorescent dye dissolved in DMSO. Culturing tubes were covered with aluminum foil to prevent exposure to light and incubated for 45 min at the same temperature. After incubation, 1 mL of culture was spun down at 6000 rpm for 5 min, the cell pellet was dissolved in medium. 1.3 µL cell suspension was loaded on a microscope slide glass with 2% agarose mixed with medium. Images were acquired on a Nikon Eclipse Ti microscope with NIS-elements AR software. Fluorescent signal was detected at excitation/emission wavelength of 488/510 nm and was shown in green. Images were processed using Fiji/ImageJ software.

Whole genome sequencing

The genomic DNA was isolated from the final stable resistant strains by the DNeasy blood and tissue kit (Qiagen). Genomic DNA libraries were generated using the NEBNext Ultra II FS DNA Library Prep kit for Illumina (New England BioLabs) in combination with NEBNext multiplex oligos for Illumina (96 Unique Dual Index Primer Pairs; New England BioLabs) according to the manufacturer’s instructions. Briefly, 500 ng genomic DNA was used as input with a fragmentation time of 5 min, aiming at an insert size distribution of 275–475 bp by following the corresponding size selection option provided in the protocol. The resulting size distribution of the libraries with indexed adapters was assessed using a 2200 TapeStation System with Agilent D1000 ScreenTapes (Agilent Technologies). The libraries were quantified on a QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific) using the NEBNext Library Quant Kit for Illumina (New England BioLabs) according to the instructions of the manufacturer. The libraries were clustered and sequenced (2 × 150 bp) on a NextSeq 550 Sequencing System (Illumina) using a NextSeq 500/550 Mid Output v2.5 kit (300 cycles) (Illumina). After sequencing, FastQC and MultiQC were used to evaluate the quality of raw reads. BBmerge was used to discover the adapter sequences, which were then imported to Cutadapt to be removed. In order to remove low-quality bases, Trimmomatic was utilized. The removal of optical duplicates was achieved via Clumpify. After mapping the reads to the reference by Bowtie2, GATK was used for marking PCR duplicates. The variant calling was done by Freebayes and used Snpeff to do the variant annotation.

Subsequently, genomic variants were identified by comparing the sequenced genome with the reference genome (NC000913) using the Variant Call Format (vcf) file, analyzed through the Integrative Genomics Viewer (IGV). Furthermore, specific mutated genes were identified by comparing antibiotic-resistant and antibiotic-free strains, excluding common variations. Copy number analysis was performed using cn.MOPS detects larger genomic alterations that result in an abnormal number of copies of one or more genes. Finally, mutated genes were functionally annotated using the Cluster of Orthologous Genes (COG) database and compared across treatment groups.

Statistical analysis

Statistical analysis was done by using IBM SPASS statistical software. The statistical significance analysis of ROS measurements was investigated using a one-way ANOVA *p < 0.05, **p < 0.001, ***p < 0.0001, Means ± SD. Other experiments not applicable.

Data Availability

The binary alignment/map (bam) files of the sequenced strains have been deposited in the NCBI database and can accessed at BioProject PRJNA954686 and PRJNA954732.

Abbreviations

ROS:

Reactive oxygen species

RMB:

Reactive metabolic byproducts

ETC:

Electron transport chain

COG:

Clusters of orthologous groups

References

  1. MacLean RC, Millan AS. “The evolution of antibiotic resistance,” Science (80-.), vol. 365, no. 6458, pp. 1082–1083, Sep. 2019, https://doi.org/10.1126/SCIENCE.AAX3879

  2. Händel N, Schuurmans JM, Feng Y, Brul S, Kuile BH. “Interaction between Mutations and Regulation of Gene Expression during Development of De Novo Antibiotic Resistance,” Antimicrob. Agents Chemother, vol. 58, no. 8, p. 4371, 2014, https://doi.org/10.1128/AAC.02892-14

  3. Hoeksema M, Jonker MJ, Brul S, Ter Kuile BH. “Effects of a previously selected antibiotic resistance on mutations acquired during development of a second resistance in Escherichia coli,” BMC Genomics, vol. 20, no. 1, pp. 1–14, Apr. 2019, https://doi.org/10.1186/s12864-019-5648-7

  4. Bombaywala S, Dafale NA, Jha V, Bajaj A, Purohit HJ. “Study of indiscriminate distribution of restrained antimicrobial resistome of different environmental niches,” Environ. Sci. Pollut. Res. Int, vol. 28, no. 9, pp. 10780–10790, Mar. 2021, https://doi.org/10.1007/S11356-020-11318-6

  5. Hoeksema M, Brul S, Ter Kuilea BH. “Influence of reactive oxygen species on de novo acquisition of resistance to bactericidal antibiotics,” Antimicrob. Agents Chemother, vol. 62, no. 6, pp. e02354-17, Jun. 2018, https://doi.org/10.1128/AAC.02354-17

  6. Händel N, Hoeksema M, Mata MF, Brul S, Ter Kuile BH. “Effects of stress, reactive oxygen species, and the SOS response on de novo acquisition of antibiotic resistance in Escherichia coli,” Antimicrob. Agents Chemother, vol. 60, no. 3, pp. 1319–1327, Mar. 2016, https://doi.org/10.1128/AAC.02684-15

  7. Hoeksema M, Jonker MJ, Bel K, Brul S, Ter Kuile BH. “Genome rearrangements in Escherichia coli during de novo acquisition of resistance to a single antibiotic or two antibiotics successively,” BMC Genomics, vol. 19, no. 1, p. 973, Dec. 2018, https://doi.org/10.1186/s12864-018-5353-y

  8. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of Cellular Death Induced by Bactericidal Antibiotics. Cell. 2007;130(5):797–810. https://doi.org/10.1016/j.cell.2007.06.049

    Article  CAS  PubMed  Google Scholar 

  9. Lobritz MA et al. “Antibiotic efficacy is linked to bacterial cellular respiration,” Proc. Natl. Acad. Sci. U. S. A, vol. 112, no. 27, pp. 8173–8180, 2015, https://doi.org/10.1073/pnas.1509743112

  10. Wong F, Stokes JM, Bening SC, Vidoudez C, Trauger SA, Collins JJ. “Reactive metabolic byproducts contribute to antibiotic lethality under anaerobic conditions,” Mol. Cell, vol. 82, no. 18, pp. 3499–3512, Aug. 2022, https://doi.org/10.1016/J.MOLCEL.2022.07.009

  11. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC. “Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics,” Science (80-.), vol. 336, no. 6079, pp. 315–319, Apr. 2012, https://doi.org/10.1126/science.1219192

  12. Degtyareva NP, Heyburn L, Sterling J, Resnick MA, Gordenin DA, Doetsch PW. “Oxidative stress-induced mutagenesis in single-strand DNA occurs primarily at cytosines and is DNA polymerase zeta-dependent only for adenines and guanines,” Nucleic Acids Res, vol. 41, no. 19, pp. 8995–9005, Oct. 2013, https://doi.org/10.1093/NAR/GKT671

  13. Mattson MP. Hormesis defined. Ageing Res Rev. Jan. 2008;7(1):1–7. https://doi.org/10.1016/J.ARR.2007.08.007

  14. Mathieu A, et al. Discovery and function of a general core hormetic stress response in E. coli Induced by Sublethal concentrations of antibiotics. Cell Rep. Sep. 2016;17(1):46–57. https://doi.org/10.1016/J.CELREP.2016.09.001

  15. Pribis JP, et al. Gamblers: an Antibiotic-Induced Evolvable Cell Subpopulation differentiated by reactive-Oxygen-Induced General stress response. Mol Cell. 2019;74(4):785–800. https://doi.org/10.1016/j.molcel.2019.02.037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kohanski MA, DePristo MA, Collins JJ. Sublethal Antibiotic Treatment leads to Multidrug Resistance via Radical-Induced Mutagenesis. Mol Cell. 2010;37(3):311–20. https://doi.org/10.1016/j.molcel.2010.01.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rodríguez-Rosado AI, et al. N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli. J Antimicrob Chemother. 2019;74(8):2188–96. https://doi.org/10.1093/jac/dkz210

    Article  CAS  PubMed  Google Scholar 

  18. Rossi E, et al. It’s a gut feeling’–Escherichia coli biofilm formation in the gastrointestinal tract environment. Crit Rev Microbiol. 2018;44(1):1–30. https://doi.org/10.1080/1040841X.2017.1303660

    Article  CAS  PubMed  Google Scholar 

  19. Kim SO, et al. OxyR: a molecular code for redox-related signaling. Cell. May 2002;109(3):383–96. https://doi.org/10.1016/S0092-8674(02)00723-7

  20. Goerlich O, Quillardet P, Hofnung M. Induction of the SOS response by hydrogen peroxide in various Escherichia coli mutants with altered protection against oxidative DNA damage. J Bacteriol. 1989;171(11):6141–7. https://doi.org/10.1128/JB.171.11.6141-6147.1989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rosner JL. Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid. Antimicrob Agents Chemother. 1993;37(10):2251–3. https://doi.org/10.1128/AAC.37.10.2251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Johanson A, Goel A, Olsson L, Franzén CJ. Respiratory physiology of lactococcus lactis in chemostat cultures and its effect on cellular robustness in frozen and freeze-dried starter cultures. Appl Environ Microbiol. Mar. 2020;86(6). https://doi.org/10.1128/AEM.02785-19/FORMAT/EPUB

  23. Brooijmans RJW, Poolman B, Schuurman-Wolters GK, De Vos WM, Hugenholtz J. Generation of a membrane potential by Lactococcus lactis through aerobic electron transport. J Bacteriol. Jul. 2007;189(14):5203–9. https://doi.org/10.1128/JB.00361-07/ASSET/A36BB487-7FCE-4C65-A330-33E8AF8B21FB/ASSETS/GRAPHIC/ZJB0140769500002.JPEG

  24. Greenberg JT, Demple B. “Overproduction of peroxide-scavenging enzymes in Escherichia coli suppresses spontaneous mutagenesis and sensitivity to redox-cycling agents in oxyR-mutants,” EMBO J, vol. 7, no. 8, pp. 2611–2617, 1988, https://doi.org/10.1002/J.1460-2075.1988.TB03111.X

  25. Händel N, Schuurmans JM, Brul S, Ter Kuilea BH. “Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in escherichia coli,” Antimicrob. Agents Chemother, vol. 57, no. 8, pp. 3752–3762, Aug. 2013, https://doi.org/10.1128/AAC.02096-12

  26. Zhao Z, et al. Systematic identification of CpxRA-Regulated genes and their roles in Escherichia coli stress response. mSystems Sep. 2022. https://doi.org/10.1128/MSYSTEMS.00419-22

    Article  Google Scholar 

  27. Morgan-Linnell SK, Boyd LB, Steffen D, Zechiedrich L. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother. 2009;53(1):235–41. https://doi.org/10.1128/AAC.00665-08

    Article  CAS  PubMed  Google Scholar 

  28. Long H et al. “Antibiotic treatment enhances the genome-wide mutation rate of target cells,” Proc. Natl. Acad. Sci. U. S. A, vol. 113, no. 18, pp. E2498–E2505, May 2016, https://doi.org/10.1073/pnas.1601208113

  29. Hostetler ZM, Cory MB, Jones CM, Petersson EJ, Kohli RM. The kinetic and molecular basis for the interaction of lexa and activated reca revealed by a fluorescent amino acid probe. ACS Chem Biol. May 2020;15(5):1127–33. https://doi.org/10.1021/ACSCHEMBIO.9B00886/ASSET/IMAGES/LARGE/CB9B00886_0004.JPEG

  30. Crane JK, Alvarado CL, Sutton MD. “Role of the SOS response in the generation of antibiotic resistance in vivo,” Antimicrob. Agents Chemother, vol. 65, no. 7, p. e0001321, Jul. 2021, https://doi.org/10.1128/AAC.00013-21

  31. Andersson DI, Hughes D. “Antibiotic resistance and its cost: is it possible to reverse resistance?” Nat. Rev. Microbiol 2010 84, vol. 8, no. 4, pp. 260–271, Mar. 2010, https://doi.org/10.1038/nrmicro2319

  32. Cretenet M, et al. Dynamic analysis of the lactococcus lactis transcriptome in cheeses made from milk concentrated by ultrafiltration reveals multiple strategies of adaptation to stresses. Appl Environ Microbiol. 2011;77(1). https://doi.org/10.1128/AEM.01174-10

  33. Wu H, et al. Contribution of YthA, a PspC family transcriptional regulator of Lactococcus lactis F44 acid tolerance and nisin yield: a transcriptomic approach. Appl Environ Microbiol. 2018;84(6). https://doi.org/10.1128/AEM.02483-17

  34. Grad YH et al. “Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000–2013,” J. Infect. Dis, vol. 214, no. 10, p. 1579, Nov. 2016, https://doi.org/10.1093/INFDIS/JIW420

  35. Izghirean N, et al. Effects of Ribosomal Protein S10 Flexible Loop mutations on tetracycline and Tigecycline susceptibility of Escherichia coli. Front Microbiol. Jun. 2021;12. https://doi.org/10.3389/FMICB.2021.663835/FULL

  36. Chen IMA et al. “The IMG/M data management and analysis system v.7: content updates and new features,” Nucleic Acids Res, vol. 51, no. D1, pp. D723–D732, Jan. 2023, https://doi.org/10.1093/NAR/GKAC976

  37. Dwyer DJ, Collins JJ, Walker GC. Unraveling the physiological complexities of antibiotic lethality. Annu Rev Pharmacol Toxicol. Jan. 2015;55:313–32. https://doi.org/10.1146/ANNUREV-PHARMTOX-010814-124712

  38. Van Acker H, Coenye T. The role of reactive oxygen species in antibiotic-mediated killing of Bacteria. Trends Microbiol. 2017;25(6):456–66. https://doi.org/10.1016/j.tim.2016.12.008

    Article  CAS  PubMed  Google Scholar 

  39. Foster-Nyarko E, Pallen MJ. The microbial ecology of Escherichia coli in the vertebrate gut. FEMS Microbiol Rev. May 2022;46(3). https://doi.org/10.1093/FEMSRE/FUAC008

  40. Brooijmans R, Smit B, Santos F, van Riel J, de Vos WM, Hugenholtz J. Heme and menaquinone induced electron transport in lactic acid bacteria. Microb Cell Fact. 2009;8:1–11. https://doi.org/10.1186/1475-2859-8-28

    Article  CAS  Google Scholar 

  41. Anand A, et al. OxyR is a convergent target for mutations acquired during adaptation to oxidative stress-prone Metabolic States. Mol Biol Evol. 2020;37(3):660–6. https://doi.org/10.1093/molbev/msz251

    Article  CAS  PubMed  Google Scholar 

  42. Guelfo JR, Rodríguez-Rojas A, Matic I, Blázquez J. A MATE-Family efflux pump rescues the Escherichia coli 8-Oxoguanine-repair-deficient mutator phenotype and protects against H2O2 killing. PLOS Genet. 2010;6(5):e1000931. https://doi.org/10.1371/JOURNAL.PGEN.1000931

    Article  PubMed  PubMed Central  Google Scholar 

  43. ter Kuile BH, Hoeksema M. Antibiotic killing through incomplete DNA repair. Trends Microbiol. Jan. 2018;26(1):2–4. https://doi.org/10.1016/J.TIM.2017.11.006

  44. Moore JM, Correa R, Rosenberg SM, Hastings PJ. “Persistent damaged bases in DNA allow mutagenic break repair in Escherichia coli,” PLOS Genet, vol. 13, no. 7, p. e1006733, Jul. 2017, https://doi.org/10.1371/JOURNAL.PGEN.1006733

  45. Ludovico P, Burhans WC. Reactive oxygen species, ageing and the hormesis police. FEMS Yeast Res. Feb. 2014;14(1):33–9. https://doi.org/10.1111/1567-1364.12070

  46. Bombaywala S, Purohit HJ, Dafale NA. Mobility of antibiotic resistance and its co-occurrence with metal resistance in pathogens under oxidative stress. J Environ Manage. Nov. 2021;297:113315. https://doi.org/10.1016/J.JENVMAN.2021.113315

  47. Shewaramani S, Finn TJ, Leahy SC, Kassen R, Rainey PB, Moon CD. Anaerobically grown Escherichia coli has an enhanced mutation rate and distinct mutational Spectra. PLoS Genet. 2017;13(1):1–22. https://doi.org/10.1371/journal.pgen.1006570

    Article  CAS  Google Scholar 

  48. Finn TJ, Shewaramani S, Leahy SC, Janssen PH, Moon CD. Dynamics and genetic diversification of Escherichia coli during experimental adaptation to an anaerobic environment. PeerJ. May 2017;2017(5):e3244. https://doi.org/10.7717/PEERJ.3244/SUPP-1

  49. Jones EC, Uphoff S. “Single-molecule imaging of LexA degradation in Escherichia coli elucidates regulatory mechanisms and heterogeneity of the SOS response,” Nat. Microbiol, vol. 6, no. 8, pp. 981–990, Jun. 2021, https://doi.org/10.1038/s41564-021-00930-y

  50. Barrett TC, Mok WWK, Murawski AM, Brynildsen MP. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic. Nat Commun. Dec. 2019;10(1):1177. https://doi.org/10.1038/s41467-019-09058-4

  51. Gutiérrez R et al. “Adaptive Resistance Mutations at Suprainhibitory Concentrations Independent of SOS Mutagenesis,” Mol. Biol. Evol, vol. 38, no. 10, pp. 4095–4115, Sep. 2021, https://doi.org/10.1093/MOLBEV/MSAB196

  52. Giese KC, Michalowski CB, Little JW. RecA-Dependent cleavage of LexA dimers. J Mol Biol. Mar. 2008;377(1):148. https://doi.org/10.1016/J.JMB.2007.12.025

  53. Ghilarov D, et al. Molecular mechanism of SbmA, a promiscuous transporter exploited by antimicrobial peptides. Sci Adv. Sep. 2021;7(37). https://doi.org/10.1126/SCIADV.ABJ5363/SUPPL_FILE/SCIADV.ABJ5363_SM.PDF

  54. Cisneros-Mayoral S, Graña-Miraglia L, Pérez-Morales D, Peña-Miller R, Fuentes-Hernández A, Barlow M. Evolutionary history and strength of selection determine the rate of Antibiotic Resistance Adaptation. Mol Biol Evol. Sep. 2022;39(9). https://doi.org/10.1093/MOLBEV/MSAC185

  55. Waxman DJ, Strominger JL. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu Rev Biochem. 1983;52:825–69. https://doi.org/10.1146/ANNUREV.BI.52.070183.004141

    Article  CAS  PubMed  Google Scholar 

  56. Redgrave LS, Sutton SB, Webber MA, Piddock LJV. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438–45. https://doi.org/10.1016/J.TIM.2014.04.007

    Article  CAS  PubMed  Google Scholar 

  57. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999;43(4):727–37. https://doi.org/10.1128/AAC.43.4.727/ASSET/BF893B4C-DA9A-4478-9734-E22D5B2F2CF3/ASSETS/GRAPHIC/AC0490264005.JPEG

    Article  CAS  PubMed Central  Google Scholar 

  58. Connell SR, Tracz DM, Nierhaus KH, Taylor DE. Ribosomal Protection Proteins and their mechanism of Tetracycline Resistance. Antimicrob Agents Chemother. Dec. 2003;47(12):3675–81. https://doi.org/10.1128/AAC.47.12.3675-3681.2003/ASSET/9502F113-F37B-4E0F-8ABA-137D4CA12FB9/ASSETS/GRAPHIC/AC1230325004.JPEG

  59. Darphorn TS, Hu Y, Sintanneland BBK, Brul S, ter Kuile BH. “Multiplication of ampC upon Exposure to a Beta-Lactam Antibiotic Results in a Transferable Transposon in Escherichia coli,” Int. J. Mol. Sci, vol. 22, no. 17, p. 9230, Aug. 2021, https://doi.org/10.3390/IJMS22179230

  60. Das S, Bombaywala S, Srivastava S, Kapley A, Dhodapkar R, Dafale NA. “Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens,” Environ. Sci. Pollut. Res. Int, vol. 29, no. 27, pp. 40507–40519, Jun. 2022, https://doi.org/10.1007/S11356-022-19840-5

  61. Baba T et al. “Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection,” Mol. Syst. Biol, vol. 2, p. 2006.0008, May 2006, https://doi.org/10.1038/MSB4100050

  62. Schuurmans JM, Nuri Hayali AS, Koenders BB, ter Kuile BH. “Variations in MIC value caused by differences in experimental protocol,” J. Microbiol. Methods, vol. 79, no. 1, pp. 44–47, Oct. 2009, https://doi.org/10.1016/J.MIMET.2009.07.017

  63. Van Der Horst MA, Schuurmans JM, Smid MC, Koenders BB, Ter BH, Kuile. “De novo acquisition of resistance to three antibiotics by escherichia coli,” Microb. Drug Resist, vol. 17, no. 2, pp. 141–147, Jun. 2011, https://doi.org/10.1089/mdr.2010.0101

Download references

Acknowledgements

We thank S. Brul for stimulating discussions and suggestions for improvement of an earlier version of the manuscript.

Funding

This study was financed by the Netherlands Food and Consumer Product Safety Authority (NVWA). The NVWA was not involved in design of the experiments, analysis of the data or writing the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

WQ and BtK conceived the project. WQ performed experiments. MJ performed the bioinformatic analysis. WQ and BtK wrote the manuscript. LT provided the knockout strain. MW and LT contributed to the final manuscript. All authors critically reviewed the manuscript and approved the final version.

Corresponding author

Correspondence to Benno H. ter Kuile.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qi, W., Jonker, M.J., Teichmann, L. et al. The influence of oxygen and oxidative stress on de novo acquisition of antibiotic resistance in E. coli and Lactobacillus lactis. BMC Microbiol 23, 279 (2023). https://doi.org/10.1186/s12866-023-03031-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12866-023-03031-4

Keywords